Unsere Übersicht
Links für Mitglieder
Links für Patienten
Kategorien
Plasmasammlung & -herstellung
Lerne alles über die Plasma-sammlung und finde zertifizierte Plasmazentren in deiner Nähe.
Informationsblätter
Factsheets bieten zusätzliche Informationen über die globale Plasmaproteintherapeutika-Industrie.
Publikationen & Präsentationen
Discover the main highlights of our industry in our latest publications.
Ressourcen für Patient:innen
Entdecke Ressourcen für Patient:innen, die an den Therapien interessiert sind.
Plasma Häufig gestellte Fragen
Erfahre mehr über Plasmatherapien und die Prozesse rund um die Spende und Entnahme.
Interessenvertretung
Erfahre mehr über die Bemühungen von PPTA, den Zugang von Patient:innen zu Therapien zu gewährleisten.
News & Pressemeldungen
Halte dich über die Neuigkeiten und Veranstaltungen von PPTA auf dem Laufenden.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Oct 1, 2021
Together toward a broader European plasma donation ecosystem
Strengthening the EU Blood Directive: To meet the needs of patients using plasma-derived medicinal products and plasma donors
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f652d7ca1569557512dc_PPTA%20Position%20Paper%20on%20the%20EU%20BTC%20revision_September2021.pdf
Oct 1, 2021
Together toward a broader European plasma donation ecosystem
Strengthening the EU Blood Directive: To meet the needs of patients using plasma-derived medicinal products and plasma donors
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f652d7ca1569557512dc_PPTA%20Position%20Paper%20on%20the%20EU%20BTC%20revision_September2021.pdf
Oct 1, 2021
Plasmavigilance-Adverse events among US Source plasma donors
Source plasma (SP) is the primary starting material for 87% of plasma-derived medicinal products globally. Plasmavigilance is a program designed to collect, analyze, and monitor donor adverse events (AEs) across the SP collection industry.
All
Publication
https://pubmed.ncbi.nlm.nih.gov/34390267/
Oct 1, 2021
Plasmavigilance-Adverse events among US Source plasma donors
Source plasma (SP) is the primary starting material for 87% of plasma-derived medicinal products globally. Plasmavigilance is a program designed to collect, analyze, and monitor donor adverse events (AEs) across the SP collection industry.
All
Publication
https://pubmed.ncbi.nlm.nih.gov/34390267/
Sep 23, 2021
Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives
The Plasma Protein Therapeutics Association (PPTA) is aware of emerging reports regarding patients not having reliable access to lifesaving plasma-derived therapies used to treat a variety of serious, rare, and chronic conditions caused by missing or deficient proteins in their blood.
All
PPTA statements
Sep 23, 2021
Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives
The Plasma Protein Therapeutics Association (PPTA) is aware of emerging reports regarding patients not having reliable access to lifesaving plasma-derived therapies used to treat a variety of serious, rare, and chronic conditions caused by missing or deficient proteins in their blood.
All
PPTA statements
Sep 1, 2021
The Source Fall 2021
Magazine of the plasma protein therapeutics industry - Fall 2021
All
The Source Magazine
https://drive.google.com/file/d/18ZMDuw0MnmyjHMdEOtrm6hWU9lt5JRMF/view?usp=sharing
Sep 1, 2021
The Source Fall 2021
Magazine of the plasma protein therapeutics industry - Fall 2021
All
The Source Magazine
https://drive.google.com/file/d/18ZMDuw0MnmyjHMdEOtrm6hWU9lt5JRMF/view?usp=sharing
Keine Ergebnisse gefunden